Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial - Ledermann, J A; Harter, P; Gourley, C (Lancet Oncol, 2016)
et al